Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 9, 2022, BioCryst Pharmaceuticals, Inc. (the "Company") approved
certain changes to its Leadership Team. Effective September 15, 2022, William P.
Sheridan, MBBS, will serve as Chief Development Officer of the Company. Dr.
Sheridan has served as the Company's Chief Medical Officer since joining the
Company in July 2008, and in his new role, he will focus on advancing the
Company's significant pipeline of development candidates.
Also effective September 15, 2022, Dr. Ryan Arnold will serve as the Company's
new Chief Medical Officer. He has served as Senior Vice President, Global
Medical Affairs of the Company since March 2022 and has more than 20 years of
industry experience, including prior roles with increasing levels of
responsibility in the medical affairs function at multiple companies.
Dr. Arnold joins Dr. Sheridan and Dr. Helen Thackray, the Company's Chief
Research and Development Officer, as physicians on the Company's Leadership
Team.
Item 7.01. Regulation FD Disclosure.
On September 14, 2022, the Company issued a press release announcing the events
described in Item 5.02 of this Current Report on Form 8-K. A copy of the press
release is furnished as Exhibit 99.1 hereto and is incorporated by reference
herein.
The information in this Item 7.01 shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), or otherwise subject to the liabilities of that section, nor shall it be
deemed incorporated by reference into any filing made by the Company under the
Securities Act of 1933, as amended, or the Exchange Act, except as expressly set
forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
Press release dated September 14, 2022 entitled "BioCryst Names
99.1 Dr. Bill Sheridan Chief Development Officer and Appoints Dr. Ryan
Arnold Chief Medical Officer"
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
© Edgar Online, source Glimpses